The underlying idea of oligonucleotide conjugates is to provide oligonucleotide with some novel property. This is achieved by tethering an unnatural organic structure and a naturally occurring small molecule of a biopolymer fragment to an unmodified or structurally modified oligonucleotide. The growing interest in oligonucleotide-based drugs during the past two decades has increased the interest in utilization of their covalently conjugated derivatives. In line with this, all the papers in this special issue have a link to either drug development or diagnostics.
obtained inhibited viral translation and replication in cell culture, serving as a proof of concept for further development towards more stable inhibitory RNA by introduction of structurally modified building blocks. Another interesting report on therapeutic oligonucleotides deals with preparation and cell culture studies of high metallacarborane-loaded antisense oligonucleotides useful in cancer boron neutron capture therapy (BNCT) [6] . The conjugates were obtained by subjecting a prefabricated oligonucleotide bearing several 2 -O-(pro-2-yn-1-yl) groups to Cu(I) catalyzed click reaction with azido functionalized boron clusters, [(3,3 -iron-1,2,1 ,2 -dicarbollide)(−1)]ates]. When targeted to epidermal growth factor receptor, the conjugate retained the silencing capacity of the unmodified oligonucleotide and exhibited anti-oxidant activity. Accordingly, the conjugates show promise for development of therapeutic agents exhibiting combined antisense/anti-oxidant and BNCT activities. The third paper on therapeutic oligonucleotides describes an integrin specific transfection agent for delivery of siRNA to tumor cells [7] . The agent was a chimeric peptide containing two cyclic structures that incorporated an Arg-Gly-Asp motif for integrin recognition and a cell penetrating arginine nonamer for enhancement of cellular uptake. This peptide was shown to internalize siRNA into HepG2 cells in vitro and to result in gene silencing.
The rest of the papers in this special issue deal with synthetic methods of oligonucleotide conjugates. Cu(I) promoted click chemistry has been used to derivatize oligonucleotides incorporating 2 -N-alkyne-2 -amino-LNA nucleosides with azido functionalized galactose or triantennary galactose cluster [8] . The conjugates obtained showed enhanced affinity and good selectivity towards complementary DNA/RNA strands. A phosphoramidite building block of ribostamycin that allow incorporation of this aminoglycoside-aminocyclitol antibiotic in any position of oligonucleotide has been synthesized [9] . The intrachain 2 -O-methyl oligoribonucleotide conjugate obtained has been shown to for a stable clamp-type triplex with DNA. Finally, preparation of triantennary N-acetylgalactosmine conjugates of antisense oligonucleotide conjugate in solution phase and on a solid support has been compared [10] . This study receives its importance from the use of this conjugate group for delivery of therapeutic oligonucleotides to liver.
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